DS
TSVT

David Shaw’s 2seventy bio TSVT Stock Holding History

David Shaw’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-13,200
Closed -$338K – 5943
2021
Q4 		$338K Buy
+13,200
New +$412K ﹤0.01% 4626

Other funds holding TSVT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

David Shaw's TSVT Position: Q4 2022 in Review

David Shaw sold out of 2seventy bio (TSVT) in Q4 2022, closing a stake of 16,866 shares — an estimated $245K sold.

David Shaw first reported a position in TSVT in Q3 2022 and held it in 1 quarter. The position peaked at $245K in Q3 2022. 142 funds tracked by Wall St. Rank hold TSVT as of Q4 2022.

  • David Shaw reported no remaining 2seventy bio position as of Q4 2022 after selling out during the quarter.
  • David Shaw sold 16,866 2seventy bio shares in Q4 2022, an estimated $245K.
  • David Shaw first reported a position in 2seventy bio in Q3 2022 and held it in 1 quarter.
  • David Shaw's 2seventy bio position peaked at $245K in Q3 2022.
  • 142 funds tracked by Wall St. Rank held 2seventy bio as of Q4 2022.

Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.